Hope is on the horizon for needle-phobic patients as Griffith University researchers have created a new influenza vaccine composition designed to be administered via the nose. Griffith University Principal Research Leader, Professor Bernd Rehm said his team reprogrammed bacterial cells to create a robust vaccine designed for intranasal delivery.
Needle-free influenza vaccine on the horizon
